Kestra Medical Technologies, Ltd. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
Kestra Medical Technologies, Ltd. (KMTS) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $3.56 million for the 12-month period ending 2025-04-30, per its 10-K filed 2026-07-14.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2026-07-14
- Kestra Medical Technologies, Ltd. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2025 was $3.56M, a 395.27% increase from fiscal 2024.
- Kestra Medical Technologies, Ltd. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was $719.00K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month |
|---|---|
| 2025-04-30 | $3.56M 10-K · filed 2026-07-14 |
| 2024-04-30 | $719.00K 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |